Delivery Order SPE2DB22D3016-SPE2DB25FAJV6
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,293.58 firm fixed-price contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.73 firm-fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD).
The contract, which has an ultimate completion date of October 30, 2024, is a part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,186.24, is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This is a firm-fixed-price delivery order contract with a completion date of January 9, 2025. The contract is not designated with a set-aside...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,820.37 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order has an ultimate completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.05 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 24, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The $11,744.46 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 17, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,015.40 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 20, 2024 and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The $3,659.72 firm fixed-price delivery order has a completion date of July 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen, the prime contractor, has an extensive Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,270.30 firm fixed-price delivery order (SPE2DB20D1100|SPE2DB25FY72H) is for the supply of Quillivant XR 25 mg/5 ml oral suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).
The contract has an ultimate completion date of October 28, 2024 and is part of a larger Indefinite...
This federal contract award, valued at $1,803.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat ADHD.
The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...